The Ensign Group, Inc. (ENSG) 株式分析

企業概要

The Ensign Group, Inc. is a prominent operator within the healthcare sector, specifically specializing in medical care facilities through its provision of skilled nursing, senior living, and rehabilitative services. The company structures its operations into two primary segments, Skilled Services and Standard Bearer, where the former focuses on delivering short and long-term nursing care for patients managing chronic conditions or prolonged illnesses. As of the latest reporting period, the enterprise holds a substantial market capitalization of $11.77 billion and generates annual revenue totaling $5.06 billion, supported by a workforce of approximately 46,000 employees. These valuation and revenue figures indicate that the company occupies a significant position within the specialized healthcare infrastructure, reflecting a large-scale operational footprint that serves a critical demographic of the aging population.

財務健全性

The company reported revenue of $5.06 billion for the trailing twelve months, with a net income of $343.97 million and an EBITDA of $528.67 million, revealing a substantial cost structure where operating expenses and taxes consume a significant portion of top-line growth. The entity generated free cash flow of $281.25 million, which underscores a robust capacity to finance capital expenditures, service acquisitions, or debt reduction without relying on external financing. Profitability analysis shows a gross margin of 16.3%, an operating margin of 9.1%, and a profit margin of 6.8%, indicating that while the business generates revenue efficiently at the gross level, the final bottom line is heavily influenced by significant operating leverage and overhead costs. Regarding liquidity and leverage, the company maintains cash reserves of $572.39 million against total debt of $2.21 billion, resulting in a high debt-to-equity ratio of 98.70% that suggests a leveraged balance sheet strategy typical for asset-heavy service providers. Short-term liquidity is supported by a current ratio of 1.42, which indicates that current assets are sufficient to cover short-term liabilities with a comfortable buffer. Return on equity stands at 16.9% while return on assets is 5.2%, metrics that collectively demonstrate management's effectiveness in generating returns for shareholders relative to the equity base and asset utilization efficiency.

バリュエーション評価

Valuation multiples for the stock include a trailing P/E ratio of 34.45 and a forward P/E of 24.47, implying that the market expects earnings growth to accelerate significantly in the coming year, thereby narrowing the valuation gap. The price-to-book ratio is recorded at 5.21, suggesting that the market assigns a substantial premium to the company's assets, likely reflecting the quality of its real estate portfolio and the scarcity of skilled nursing facilities. Alternative valuation metrics such as a price-to-sales ratio of 2.33 and an EV/EBITDA of 25.09 provide additional context, indicating that investors are willing to pay a premium for revenue and earnings power beyond traditional asset valuations. The 52-week trading range spans from a low of $118.73 to a high of $218.00, and depending on the current market price, the stock trades within this established volatility band, though the specific current price is not explicitly defined in the provided facts. The beta of 0.82 indicates that the stock's price volatility is lower than the broader market, suggesting a defensive characteristic often found in healthcare utility-like businesses.

Growth & Income

Revenue growth for the trailing twelve months stands at 20.2%, while earnings growth is recorded at 18.4%, demonstrating that earnings are expanding slightly slower than revenue, which may imply that cost inflation or margin compression is currently outpacing top-line expansion. The company currently offers a dividend yield of 0.1% with a payout ratio of 4.3%, a conservative level that indicates the dividend is highly sustainable given the low portion of earnings distributed. This minimal payout ratio suggests that the majority of earnings are retained within the business to fund organic growth, debt repayment, or potential strategic acquisitions rather than being returned to shareholders immediately. Overall, the company presents a profile characterized by double-digit revenue expansion and a highly sustainable, albeit minimal, dividend policy that prioritizes internal reinvestment over aggressive shareholder returns.